Tweet
Is there a program that can estimate the heterozygosity of a sample using the kmer frequency distribution of the raw reads? I have whole genome, Illumina data (100bp PE reads, from 300bp fragments). The kmer frequency plot has a clear bimodal distribution, so I can get a rough estimate by eyeballing the areas under the curves for the two peaks. I am hoping to find a more robust method and more automated since I have over 100 samples.
-
-
push
Actually I have no responds neither, I am afraid.
I am just asking myself the same question and wondered whether you were able to solve that question ? -
Perhaps you want to look into Ka/Ks estimation.Comment
-
I just came across this paper on arxiv "Estimation of genomic characteristics by analyzing k-mer frequency in de novo genome projects"
I have not tried their tool though! It is available at ftp://ftp.genomics.org.cn/pub/gce/
Best,
~wormSeeq.Comment
-
Hmmm, I wrote a program that does this. Well, two, actually. Their usage is about the same.
khist.sh in=reads.fq khist=khist.txt peaks=peaks.txt
or
kmercountexact.sh in=reads.fq khist=khist.txt peaks=peaks.txt
The first uses approximate counts, while the second uses exact counts (and thus potentially more memory). The peaks file header contains estimates of genome size and heterozygousity. You can also add the flag "ploidy=2" for diploid organisms, so that it won't need to autodetect the ploidy (and thus potentially make a mistake).
These are both distributed with BBTools.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment